Archives

by in
Entry Author Date Location
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
Armo BioSciences Joins the Cancer Immunotherapy Party With $20M 11/25/13 San Francisco
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
Big Pharma Quartet Puts $30M Behind Aileron’s P53 Peptide Drug 11/18/13 Boston
Dendreon Cuts 150 Jobs, As Prostate Cancer Drug Sales Decline 11/12/13 Seattle
Immunogen Halts Study as Cancer Drug Flops, Shares Fall 11/05/13 Boston
Genentech Does it Again, Wins FDA Approval for ‘Son of Rituxan’ 11/01/13 San Francisco
Immune Design Grabs $32.5M, Cashing in on Cancer Immunotherapy Rush 10/30/13 Seattle
The Biggest Bargains Pharma Scooped Up in the Down Years 10/28/13 National
PSivida, Alimera Shares Fall as FDA Rejects Eye Drug for Third Time 10/18/13 Boston
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
East Coast Life Sciences Roundup: Moderna, Inotek, Roche, & More 10/04/13 Boston
NJ’s Pain is NY’s Gain as Roche Christens Manhattan Collaboration Hub 10/01/13 New York
Sutro Aims to Deliver Anti-Tumor “Warheads” More Precisely 10/01/13 San Francisco
Ophthotech Prices IPO at $22 Per Share, Reels in $167M 09/24/13 New York
East Coast Life Sciences Roundup: Genocea, Biogen, OvaScience, & More 09/13/13 Boston
Broad Institute Joins up with Bayer to Find Targeted Cancer Drugs 09/10/13 Boston
Are Some Degrees Better than Others for Big Pharma Leaders? 09/09/13 Seattle
Aileron Goes After Cancer’s Hard Target, P53, With Peptide Drug 09/03/13 Boston
Adimab Teams Up With Celgene, Innovent, in Latest Partnership Deals 08/20/13 Boston
Ophthotech Eyes $85M IPO With Late-Stage Clinical Trial in Sight 08/15/13 New York
Regeneron Targets New Market for Blockbuster Eye Drug 08/06/13 New York
Ensemble Reels in Novartis to Develop Oral, Mid-Sized Inflammation Drugs 08/06/13 Boston
Adimab Turns Cash Flow Positive With GSK, Biogen Tech Transfer Deals 07/26/13 Boston
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut 07/24/13 Boston
Ensemble Adds to Cast of Partners With Alexion Deal 07/18/13 Boston
Alkermes Adds Cancer, MS Drugs To Growing Portfolio 07/17/13 Boston
San Diego Life Sciences Roundup: Halozyme, Pathway Genomics, Avanir 07/03/13 San Diego
Baseball and Biopharma: More Alike Than You Might Realize 07/03/13 Seattle
CytomX Snags $25M From Pfizer to Make Souped-Up Antibodies 06/06/13 San Francisco
Page 2 of 14 « previous page · next page »